Eric Michael Thompson, MD in Plymouth, MN - Medicare Family Practice

Eric Michael Thompson, MD is a medicare enrolled "Family Medicine" physician in Plymouth, Minnesota. He went to University Of North Dakota School Of Medicine and graduated in 1999 and has 25 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Sanford Medical Center Fargo and his current practice location is 2805 Campus Dr Ste 115, Plymouth, Minnesota. You can reach out to his office (for appointments etc.) via phone at (763) 577-7800.

Eric Michael Thompson is licensed to practice in Minnesota (license number 75458) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1043242290.

Contact Information

	Eric Michael Thompson, MD
	2805 Campus Dr Ste 115, Plymouth, MN 55441-2677
	(763) 577-7800
	(763) 577-7855

Physician's Profile

Full Name	Eric Michael Thompson
Gender	Male
Speciality	Family Practice
Experience	25 Years
Location	2805 Campus Dr Ste 115, Plymouth, Minnesota
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Eric Michael Thompson attended and graduated from University Of North Dakota School Of Medicine in 1999

NPI Data:

NPI Number: 1043242290
Provider Enumeration Date: 07/07/2006
Last Update Date: 12/27/2023

Medicare PECOS Information:

PECOS PAC ID: 7911811526
Enrollment ID: I20070824000415

Medical Identifiers

Medical identifiers for Eric Michael Thompson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043242290	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	11080 (South Dakota)	Secondary
207Q00000X	Family Medicine	75458 (Minnesota)	Primary
207Q00000X	Family Medicine	10636 (North Dakota)	Secondary
207Q00000X	Family Medicine	53362991205 (Utah)	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Sanford Medical Center Fargo	Fargo, ND	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Sanford Medical Center Fargo	8426967803	1094

News Archive

Researchers to identify rare genetic mutation to produce histamine against TS

A single, very unusual family with Tourette syndrome has led Yale School of Medicine researchers to identify a rare mutation in a gene that is required to produce histamine. The finding provides a new framework to understand many years of data on the role of histamine function in the brain and points to a potentially novel approach to treatment of tics and Tourette.

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Amneal Pharmaceuticals, LLC has announced the execution of an Asset Purchase Agreement for Amneal's wholly-owned subsidiary, Amneal Pharmaceuticals of New York, LLC, to acquire the assets, facilities and business of Interpharm. The acquisition includes Interpharm's facilities on Long Island, New York as well as the intellectual property including ANDA's, technology and processes.

Utah researchers receive $1.4 million to develop implantable neural interface

University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Celator Pharmaceuticals, Inc. today announced that the Phase 3 clinical trial of VYXEOS (cytarabine:daunorubicin) Liposome for Injection (also known as CPX-351) in patients with untreated high-risk (secondary) acute myeloid leukemia (AML) has reached its pre-specified number of events required for the analysis of overall survival.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Eric Michael Thompson allows following entities to bill medicare on his behalf.

Entity Name	Sanford Bismarck
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403

News Archive

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Entity Name	Sanford Medical Center Fargo
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eric Michael Thompson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Eric Michael Thompson, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-9000	Eric Michael Thompson, MD 2805 Campus Dr Ste 115, Plymouth, MN 55441-2677 Ph: (763) 577-7800

News Archive

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Family Medicine Doctors in Plymouth, MN

Melanie A Hoiland, PA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1495 Hwy 101 N, Plymouth, MN 55447 Phone: 763-476-6776
Dr. Shelly L Anderson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1495 Hwy 101 North, Plymouth, MN 55447 Phone: 763-476-6776
Mr. Mancel Talcott Mitchell Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15655 37th Ave N Ste 100, Plymouth, MN 55446 Phone: 763-587-7900 Fax: 763-587-7701
Lawrence Gale Richmond, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4155 County Road 101 N, Plymouth, MN 55446 Phone: 952-993-8900
Christine S Chang, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12805 Highway 55, Suite 111, Plymouth, MN 55441 Phone: 763-577-2060 Fax: 763-577-2099
David S. Johnson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Suite 400, Plymouth, MN 55441 Phone: 763-577-7400

Eric Michael Thompson, MD - Medicare Family Practice in Plymouth, MN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Medicare Reassignments

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Researchers to identify rare genetic mutation to produce histamine against TS

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Utah researchers receive $1.4 million to develop implantable neural interface

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Family Medicine Doctors in Plymouth, MN